STOCK TITAN

ALEC insider files Form 144 to sell 14,000 restricted shares via Morgan Stanley

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Alector, Inc. (ALEC) filed a Form 144 reporting a proposed sale of 14,000 shares of common stock, scheduled to be sold through Morgan Stanley Smith Barney LLC on 08/26/2025 on Nasdaq for an aggregate market value of $32,996.60. The filer reports total shares outstanding of 101,212,329. The shares were acquired as restricted stock from the issuer on 06/11/2025, with payment dated the same day. No securities sales by the filer in the past three months are reported. The filer affirms they are not aware of undisclosed material adverse information and includes the standard signature and certification language required by Rule 144.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Small insider sale of restricted shares; immaterial to capitalization but notable as a recently acquired restricted stock disposition.

The filing documents a relatively small proposed sale representing approximately 0.0138% of the reported outstanding shares (14,000 of 101,212,329). The transaction involves restricted stock granted by the issuer on 06/11/2025 and planned brokerage execution through Morgan Stanley on 08/26/2025. Given the low absolute value (<$33k) versus total shares outstanding, this is unlikely to move market valuations or indicate a broad insider sell-down, though investors may note timing and the fact the securities were recently issued.

TL;DR: Compliance filing appears routine and appropriately discloses a proposed sale under Rule 144.

The Form 144 contains required disclosures: broker details, acquisition as restricted stock from the issuer, and the filer’s representation about material nonpublic information. It reports no sales in the prior three months, which supports that this is an isolated, authorized disposition. From a governance perspective, documentation is complete for a Rule 144 notice and does not by itself signal governance or disclosure concerns.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did Alector (ALEC) report on this Form 144?

The filer reported a proposed sale of 14,000 common shares through Morgan Stanley on 08/26/2025, with aggregate market value $32,996.60.

How and when were the shares being sold acquired?

The shares were acquired as restricted stock from the issuer on 06/11/2025, with payment dated 06/11/2025.

How many Alector shares are outstanding per the filing?

The filing lists 101,212,329 shares outstanding.

Did the filer report other sales in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months.

Through which broker will the sale be executed?

The sale is to be executed through Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza.
Alector

NASDAQ:ALEC

ALEC Rankings

ALEC Latest News

ALEC Latest SEC Filings

ALEC Stock Data

210.66M
98.25M
10.37%
77.1%
5.36%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO